ELUMIBUS 0.1 mg/g, eye gel in a single-dose container 30 single-dose containers of 0.3 g
Active ingredients: Bimatoprost
Commercialized according to BDPMDispensing in France: Prescription only
Gel30 single-dose containers of 0.3 gophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ELUMIBUS 0,1 mg/g, gel ophtalmique en récipient unidose
- Pharmaceutical form
- gel
- Route of administration
- ophtalmique
- Presentation description
- 30 (3 x10) récipients unidoses polyéthylène basse densité (PEBD) suremballés/surpochés de 0,3 g
- Marketing authorisation holder
- THEA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 29 May 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65513239CIP73027455CIP133400930274552Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BIMATOPROSTgel | 0,1 mg · 1 g de gel | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.